Skip to main content

Biotech Investor Relations: Strategy and Tactics for Success in a New Era

BiotechIR

Dec
9
2016

Date: December 9, 2016

Time: 8:30AM

Location: Cambridge, MA

Topics

  • Graduate-level Disclosure Management
     

About the Event 

The Biotech IR Summit is a forum where communications leaders across the life sciences will share best practices and the most challenging experiences facing members of the biotech IR community today. The agenda includes talks, expert-moderated panels and interactive workshops focused on the most sensitive IR and disclosure topics: bringing the IRO to the strategic decision-making table; working with activist shareholders; best practices for crisis management; managing social media in the financial world and IR/Clinical integration.

Conference faculty includes IROs from large and small cap companies, public company Chief Financial officers and members of the buyside and sellside and regulatory professionals. This agenda provides actionable information for the senior and junior IRO alike, based on a dual-track session of the program that offers tactical IR primers to IR newcomers while experienced members participate in senior strategic discussions.

Who should attend

  • CEOs, CFO, or other management members of companies preparing to go public
  • CEOs and CFOs and IROs in public companies as well as team members moving into Investor Relations from other roles
  • Media professionals who wish to align financial community interactions and messaging with their communications planning and programs

Speakers

Professional Cropped Gates Megan Mintz

Megan N. Gates

Panelist

Megan N. Gates is a Mintz corporate and securities attorney who guides public companies through capital-raising transactions, SEC reporting obligations, and mergers and acquisitions. She advises clients on corporate governance and SEC compliance matters in the life sciences and other industries.